Cargando…
Dosing down with biologic therapies: a systematic review and clinicians’ perspective
The effectiveness of biologic therapies now means that remission or low disease activity are realistic targets for treatment. However, after achieving remission/low disease activity, the next steps remain unclear. The aim of this publication was to conduct a broad systematic literature review to eva...
Autores principales: | Edwards, Christopher J, Fautrel, Bruno, Schulze-Koops, Hendrik, Huizinga, Tom W J, Kruger, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850865/ https://www.ncbi.nlm.nih.gov/pubmed/28339632 http://dx.doi.org/10.1093/rheumatology/kew464 |
Ejemplares similares
-
Dosing down with biologic therapies: a systematic review and clinicians’ perspective
por: Edwards, Christopher J, et al.
Publicado: (2018) -
Where is biological therapy going?
por: Schulze-Koops, Hendrik, et al.
Publicado: (2000) -
Aktueller Stand der Impfung gegen SARS-CoV-2
por: Iking-Konert, Christof, et al.
Publicado: (2021) -
Lymphopenia and autoimmune diseases
por: Schulze-Koops, Hendrik
Publicado: (2004) -
Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases
por: Schulze-Koops, Hendrik
Publicado: (2017)